The White Label Problem Nobody Talks About
The majority of CBD brands on the market today do not formulate their own products. They purchase pre-made extracts — often from the same handful of contract manufacturers — and apply their own label, their own branding, and their own price point. The product inside the bottle is functionally identical to dozens of other brands on the market.
This is called white labeling, and it is the dominant business model in the cannabinoid industry.
White labeling is not inherently fraudulent — but it creates a fundamental problem: the brand selling the product has limited visibility into how it was formulated, limited ability to control batch-to-batch consistency, and limited accountability for what's actually in the bottle. When a 2017 JAMA study found that 69% of online CBD products were mislabeled, white labeling was a primary contributing factor.
What a Standardized Cannabinoid Formulation Actually Is
A standardized cannabinoid formulation is one that has been engineered to deliver a defined, consistent concentration of specific cannabinoids — verified by independent laboratory testing — across every batch produced. It is the cannabinoid equivalent of a pharmaceutical-grade product.
Standardization requires:
- In-house formulation development — the brand must develop and control its own formulation, not purchase a pre-made extract
- Defined cannabinoid specifications — target concentrations for each cannabinoid (CBD, CBG, CBN, CBC) must be established and documented
- Raw material quality control — incoming hemp extract must be tested and verified before use in formulation
- In-process testing — cannabinoid concentrations must be verified during manufacturing, not just at the finished product stage
- Finished product testing — every batch of finished product must be tested by an independent, ISO/IEC 17025-accredited laboratory
- Batch-specific COA publication — results must be published for the specific batch the consumer purchased, not a generic reference batch
Why Standardization Is Harder Than It Sounds
Hemp is an agricultural product. Cannabinoid concentrations in raw hemp vary by cultivar, growing conditions, harvest timing, and post-harvest handling. Achieving consistent cannabinoid concentrations in a finished product requires sophisticated extraction, purification, and blending processes — and the formulation expertise to execute them reproducibly.
This is why most brands don't do it. It requires investment in equipment, expertise, and quality systems that are incompatible with the white-label model. It is significantly easier — and more profitable in the short term — to purchase a pre-made extract, apply a label, and market aggressively.
How to Identify a Truly Standardized Product
Use this checklist before purchasing any cannabinoid product:
- ✅ Does the brand formulate in-house? Look for explicit statements that the brand develops its own formulations. Absence of this claim is a red flag.
- ✅ Are batch-specific COAs published? The COA must reference your specific batch or lot number — not a generic sample.
- ✅ Is the testing laboratory ISO/IEC 17025-accredited? This is the international gold standard for laboratory competence. Verify accreditation independently if possible.
- ✅ Does the COA cover full-panel testing? Potency alone is insufficient. Heavy metals, pesticides, residual solvents, and microbials must all be tested and reported.
- ✅ Are results consistent across multiple batches? Compare COAs from different batches. Significant variation in cannabinoid concentrations indicates poor standardization.
- ✅ Does the brand publish all results, not just passing ones? Selective disclosure is not transparency.
Frequently Asked Questions
What is the difference between standardized and non-standardized CBD?
A standardized CBD product delivers a verified, consistent cannabinoid concentration in every batch — confirmed by independent laboratory testing. A non-standardized product may vary significantly in potency from batch to batch, as documented in multiple peer-reviewed studies including the 2017 JAMA analysis.
How do I know if a CBD brand white-labels its products?
Ask directly. A brand that formulates its own products will say so explicitly and be able to describe their formulation process. Brands that white-label typically use vague language about "sourcing premium hemp" without describing their formulation methodology. The absence of a named formulator or scientist is also a strong indicator.
Why does standardization matter for dosing?
If cannabinoid concentrations vary batch to batch, your effective dose changes every time you open a new bottle — even if you're taking the same volume. Standardization ensures the dose you establish through titration remains consistent over time.
The cbdDR Difference
cbdDR was founded in 2014 by Matthew Scott, a botanical scientist, specifically because the market lacked standardized cannabinoid formulations. Every cbdDR product is:
- Formulated in-house by Matthew Scott — not white-labeled
- Engineered to defined cannabinoid specifications
- Tested by ISO/IEC 17025-accredited independent laboratories
- Published batch-by-batch in our Batch Database
- Never released if it fails any testing parameter
We don't ask you to trust our marketing. We ask you to verify our science. Start with our Batch Database →
Related Articles
- Why Standardization Is the Most Important Word in Cannabinoid Wellness
- Broad Spectrum vs. CBD Isolate: A Scientific Comparison
- What Is Broad Spectrum CBD? A Complete Science-Based Guide
- Our Story — Founded on Science Since 2014
- Batch Database — Verify Your Product
References
- Bonn-Miller MO, et al. (2017). Labeling Accuracy of Cannabidiol Extracts Sold Online. JAMA, 318(17), 1708–1709. PMID: 29114823
- Vandrey R, et al. (2015). Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products. JAMA, 313(24), 2491–2493. PMID: 26103034
- ISO/IEC 17025:2017. General requirements for the competence of testing and calibration laboratories. International Organization for Standardization.
- U.S. Food and Drug Administration. (2020). FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD).
cbdDR does not make disease treatment claims. All formulations are hemp-derived and federally legal under the 2018 Farm Bill. Consult a qualified healthcare provider for medical advice.